Experienced in Primary Immunodeficiency (PID)

Dr. Louis C. Garrot

Hematology | Oncology
790 Church Street Northeast, Suite 335, 
Marietta, GA 
Accepting New Patients
Experienced in Primary Immunodeficiency (PID)
790 Church Street Northeast, Suite 335, 
Marietta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Louis Garrot is a Hematologist and an Oncologist in Marietta, Georgia. Dr. Garrot is rated as an Experienced provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Lymphofollicular Hyperplasia, Familial Prostate Cancer, and Familial Pancreatic Cancer. Dr. Garrot is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Louisiana State University School Of Medicine, 1999
Residency
Louisiana State University, Internal Medicine, 2002
Specialties
Hematology
Oncology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine - Hematology
American Board Of Internal Medicine - Medical Oncology
Fellowships
Beth Israel Deaconess Medical Center, Medical Oncology, 2007
Hospital Affiliations
Northside Hospital Forsyth
Wellstar Cobb Medical Center
Northside Hospital Cherokee
Wellstar Kennestone Regional Medical Center
Northside Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Georgia Cancer Specialists
790 Church Street Northeast, Suite 335, Marietta, GA 30060

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
View 2 Less Clinical Trials
Similar Doctors
Jonathan C. Bender
Advanced in Primary Immunodeficiency (PID)
Dr. Jonathan C. Bender
Oncology | Hematology
Advanced in Primary Immunodeficiency (PID)
Dr. Jonathan C. Bender
Oncology | Hematology

Piedmont Cancer Institute, PC

1267 Highway 54 West, Suite 4200, 
Fayetteville, GA 
 (49.6 miles away)
678-829-1060
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Bender is a Hematologist and an Oncologist in Fayetteville, Georgia. Dr. Bender is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia. Dr. Bender is currently accepting new patients.

Advanced in Primary Immunodeficiency (PID)
Dr. William S. Jonas
Hematology Oncology | Hematology | Oncology
Advanced in Primary Immunodeficiency (PID)
Dr. William S. Jonas
Hematology Oncology | Hematology | Oncology

Piedmont Cancer Institute PC

1800 Howell Mill Rd Nw, Suite 800, 
Atlanta, GA 
 (27.6 miles away)
404-350-9853
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

William Jonas is a Hematologist Oncology specialist and a Hematologist in Atlanta, Georgia. Dr. Jonas is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Childhood Iron Deficiency Anemia. Dr. Jonas is currently accepting new patients.

Experienced in Primary Immunodeficiency (PID)
Dr. Satvir Singh
Hematology | Oncology
Experienced in Primary Immunodeficiency (PID)
Dr. Satvir Singh
Hematology | Oncology

Suburban Hematology Oncology Associates

1700 Tree Lane, Suite 490, 
Snellville, GA 
 (31.3 miles away)
770-979-2828
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Satvir Singh is a Hematologist and an Oncologist in Snellville, Georgia. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Singh is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Garrot's expertise for a condition
ConditionClose
    View All 54 Advanced Conditions
    View All 136 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile